PriceTargets.com logo

CNSX:BE - Beleave Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 05/22/2020 01:00 AM ET
+0.30 (1.20%)

This chart shows the closing price for BE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Beleave Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BE

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Beleave in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for BE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Beleave. This rating has held steady since February 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/13/2019Fundamental ResearchDropped CoverageBuy ➝ Buy$0.60 ➝ $0.57
12/24/2018Fundamental ResearchLower Price TargetBuy ➝ Buy$0.67 ➝ $0.60
10/23/2018Fundamental ResearchBoost Price TargetTop Pick ➝ Top Pick$3.53 ➝ $4.62
5/3/2018Fundamental ResearchInitiated CoverageTop Pick$3.53
(Data available from 6/21/2016 forward)

Beleave

Beleave Inc., together with its subsidiaries, cultivates, produces, and sells tetrahydrocannabinol and cannabidiol medical cannabis in Canada and Colombia. The company produces cannabis oils and extracts for medical purposes. It also operates a network of medical cannabis clinics under the Medi-Green banner. Beleave Inc. is headquartered in Hamilton, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

777,666 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Beleave?

The following Wall Street sell-side analysts have issued stock ratings on Beleave in the last year:
View the latest analyst ratings for BE.

What is the current price target for Beleave?

0 Wall Street analysts have set twelve-month price targets for Beleave in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Beleave in the next year.
View the latest price targets for BE.

What is the current consensus analyst rating for Beleave?

Beleave currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BE.

What other companies compete with Beleave?

Other companies that are similar to Beleave include Canopy Growth, Innovative Industrial Properties, Leaf Mobile, GrowGeneration, OrganiGram, 22nd Century Group, Emblem, ICC Labs, Bioventix, KushCo, Terra Tech, General Cannabis, Net Savings Link, MassRoots and Grow Capital.